OpenAI Adds New GPT-Rosalind-Discovery Model to API, Purpose Unclear

A second variant of OpenAI's specialized life-sciences model has surfaced on the company's API pricing page without official announcement, raising questions about its intended application in drug discovery workflows. The new model, called gpt-rosalind-discovery, appears alongside the already-available gpt-rosalind-research on OpenAI's developers platform, both priced identically at $5 per million input tokens, $0.50 per million cached input tokens, and $25 per million output tokens. The discovery variant's specific purpose remains undisclosed, though the model naming and pricing parity with the research version suggest it may occupy a distinct niche within the GPT-Rosalind family.